Persistence of Cisplatin-Induced Mutagenicity in Hematopoietic Stem Cells: Implications for Secondary Cancer Risk Following Chemotherapy

Cisplatin is a cytostatic agent used in the treatment of many types of cancer, but its use is associated with increased incidences of secondary leukemia. We evaluated cisplatin's in vivo genotoxic potential by analyzing peripheral blood for Pig-a mutant phenotype erythrocytes and for chromosoma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dertinger, Stephen D., Avlasevich, Svetlana L., Torous, Dorothea K., Bemis, Jeffrey C., Phonethepswath, Souk, Labash, Carson, Carlson, Kristine, Mereness, Jared, Cottom, John, Palis, James, MacGregor, James T.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Genetic Toxicology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176048/
https://ncbi.nlm.nih.gov/pubmed/24798381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/toxsci/kfu078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados